A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.
According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...
Much like radio operators being encouraged to use the least possible amount of power to make a contact, chemists have a ...
Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...
Daisy-chaining two of Dell's Nvidia GB10 DGX Spark systems didn't just pump up my home AI lab—it fundamentally changed how I ...
What if the mechanical properties of a cell could be programmed like the components of a machine? Researchers at the ...
A major breakthrough in quantum technology has turned magnons, tiny magnetic waves once considered too short-lived for ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...